Lexel S.R.L is an Argentinian company dedicated to the production, investigation, development and sale in the medical device sector. It was founded in 1991 since then has become one of the company leaders of the Argentinian market. In 1997 it moved into MERCOSUR and some countries of Latin America.
Lexel has a maufacturing plant in Argentina, which is certified in ISO9001;2000, ISO13485;2003 and GMP (Good Manufacturing Practice). The company also has the CE mark for their products that allows to them to sell in European Union. CE 0473.
GSK’s Consumer Healthcare’s regional manager for the southern cone discusses the countries longstanding commitment to the Argentinian consumer and how this history allows them to succeed in a country typically dominated…
The president of Laboratorios Richmond discusses the lab’s upcoming launch of the first branded generic HIV product and the firm’s prospects for growth in export markets. In 2011 Laboratorios…
Adrian Fernandez, current CEO, shares his experience of taking a domestic company international and the viability of the family business model in the contemporary market. As a rapidly internationalizing…
The Argentinian healthcare system is subject to rules, in which delivery agreements for medicines to health insurance agents undergo health funders guidelines and other regulations imposed by the Superintendency of…
The president of Denver Farma explains how crucial exports are for his company, especially to countries like Brazil where the market participation of local companies is small, and multinational companies…
Edgardo Vázquez, Pfizer’s country manager for the Argentina Region, discusses the company’s investment strategies across their newly established business units and a few of the unique challenges presented by the…
The CEO and one of the founders of Lexel explains how the company adapts its medical devices to the specifications required by their international customers. Why did Lexel enter…
Carlos Chiale, National Administrator of ANMAT, discusses the agency’s latest strategy implementation and its pioneering work in the area of fighting drug falsification. Could you provide a historical overview…
The general manager of Sandoz South Latam weighs up the factors that have allowed his company to be the leader in biosimilars and differentiated generics. Could you please…
The vice president of Laboratorios Beta discusses the factors of why his organization is on the way to consolidating its different business lines and becoming a pure pharmaceutical company. …
The general director of pharma in Argentina for the Bagó group explains why his group has planned that 75 percent of turnover will come from international markets in the coming years. 2014 marks…
The executive coordinator of GACTEC maps the current level of science and technology in Argentina and outlines the country’s ambitions in this area, which is to have an impact on innovation at…
See our Cookie Privacy Policy Here
